Cirugía y Especialidades Médico-Quirúrgicas
Département
MARIO
FERNANDEZ FRAGA
Profesor Asociado
Publications dans lesquelles il/elle collabore avec MARIO FERNANDEZ FRAGA (20)
2024
-
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
eBioMedicine, Vol. 102
-
PCDHGC3 hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas
Journal of Pathology, Vol. 263, Núm. 4-5, pp. 418-428
2023
-
CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer
Clinical Epigenetics, Vol. 15, Núm. 1
-
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma
Nature Communications, Vol. 14, Núm. 1
2022
-
Classification of follicular-patterned thyroid lesions using a minimal set of epigenetic biomarkers
European journal of endocrinology, Vol. 187, Núm. 3, pp. 335-347
2021
-
Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma
Frontiers in Cell and Developmental Biology, Vol. 9
2020
-
Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis
International Journal of Cancer, Vol. 146, Núm. 2, pp. 373-387
2019
-
Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations
The Journal of clinical endocrinology and metabolism, Vol. 104, Núm. 11, pp. 5673-5692
2018
-
Epigenetic dysregulation of TET2 in human glioblastoma
Oncotarget, Vol. 9, Núm. 40, pp. 25922-25934
-
Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma
Human Molecular Genetics, Vol. 27, Núm. 17, pp. 3046-3059
-
SDHC promoter methylation, a novel pathogenic mechanism in parasympathetic paragangliomas
Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 1, pp. 295-305
2016
2014
-
Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia
Nature Communications, Vol. 5
2013
-
DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease
Brain, Vol. 136, Núm. 10, pp. 3018-3027
-
DNA methylation signatures identify biologically distinct thyroid cancer subtypes
Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 7, pp. 2811-2821
-
Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion
Nature Communications, Vol. 4
2012
-
A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer
European Journal of Cancer, Vol. 48, Núm. 14, pp. 2270-2281
-
Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: Pathobiological mechanisms and clinical implications
Journal of Molecular Medicine, Vol. 90, Núm. 10, pp. 1173-1184
-
Hypomethylation of LINE-1, and not centromeric SAT-a, is associated with centromeric instability in head and neck squamous cell carcinoma
Cellular Oncology, Vol. 35, Núm. 4, pp. 259-267
2010
-
Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
Molecular Cancer, Vol. 9